Two recently finalized cases against Latin America states provide several noteworthy points for further debates on the host states’ counterclaims towards investors.
Médecins Sans Frontières (MSF) raises concerns over provisions under negotiation in the RCEP investment chapter that threaten to restrict access to affordable medicines for millions of people
Fresh investments by European companies in India and vice versa after April 1 won’t enjoy legal protection under any bilateral arrangement, as India has decided not to accede to requests by the European Union.
People’s Coalition on Food Sovereignty | 2-Mar-2017
RCEP will be harmful to developing countries’ struggle for industrialization, access to cheaper medicines, quality social services, and protection of the environment